United States Financial Technology (Fintech) & Infrastructure

Stablecoin Development Corp (SDEV)

Track

Track

NovaBay Pharmaceuticals Inc. recorded recent insider trading activity on June 15, 2026, involving multiple sell transactions by the Chief Executive Officer and associated entities. These divestments follow a series of share acquisitions conducted by Poplar Point Capital Partners LP throughout March and April 2025.
Ticker: SDEV Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Stablecoin Development Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kazley Michael John Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
160.78
Quantity 58,210 -4.5%
Value US$108,437
R01 Fund LP Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
351.95
Quantity 97,387 -12.8%
Value US$2,435,846
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Sale
Price
1.81
Quantity 1
Value US$2
1.8
Kunin Audrey Chief Product Officer Officer
Transaction date
Sale
Price
1.81
Quantity 1
Value US$2
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Sale
Price
2.10
Quantity 5,960 -100.0%
Value US$12,545
1.8
Kunin Audrey Chief Product Officer Executive Director
Transaction date
Sale
Price
2.10
Quantity 5,960 -100.0%
Value US$12,545
1.1
Hall Justin CEO, GC and Director Executive Director
Transaction date
Purchase
Price
0.15
Quantity 10,000 +13.7%
Value US$1,500
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Sale
Price
0.16
Quantity 291,368 -58.3%
Value US$46,094
1.8
Kunin Audrey Chief Product Officer Executive Director
Transaction date
Sale
Price
0.16
Quantity 291,368 -58.3%
Value US$46,094
1.1
Hall Justin CEO, GC and Director Executive Director
Transaction date
Purchase
Price
0.43
Quantity 69,767 +2049.0%
Value US$30,000
0.9
Jones Andrew D. CFO Officer
Transaction date
Purchase
Price
0.44
Quantity 36,765 +40.5%
Value US$16,177
1.8
Kunin Audrey Chief Product Officer Officer
Transaction date
Purchase
Price
0.46
Quantity 101,650 +25.5%
Value US$47,013
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Purchase
Price
0.46
Quantity 101,650 +25.5%
Value US$47,013
0.9
Jones Andrew D. CFO Officer
Transaction date
Purchase
Price
0.44
Quantity 8,690 +10.6%
Value US$3,824
1.8
Kunin Audrey Chief Product Officer Officer
Transaction date
Purchase
Price
0.48
Quantity 262,369 +192.9%
Value US$124,888
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Purchase
Price
0.48
Quantity 262,369 +192.9%
Value US$124,888
1.8
Kunin Audrey Chief Product Officer Officer
Transaction date
Purchase
Price
0.49
Quantity 14,848 +12.3%
Value US$7,276
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Purchase
Price
0.49
Quantity 14,848 +12.3%
Value US$7,276
1.8
Kunin Audrey Chief Product Officer Officer
Transaction date
Purchase
Price
0.46
Quantity 30,000 +32.9%
Value US$13,800
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Purchase
Price
0.46
Quantity 30,000 +32.9%
Value US$13,800
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Purchase
Price
0.46
Quantity 66,133 +264.5%
Value US$30,368
1.8
Kunin Audrey Chief Product Officer Officer
Transaction date
Purchase
Price
0.46
Quantity 66,133 +264.5%
Value US$30,368
1.8
Kunin Jeffrey President, DERMAdoctor, LLC Officer
Transaction date
Purchase
Price
0.46
Quantity 25,000 +inf%
Value US$11,500
1.8
Kunin Audrey Chief Product Officer Officer
Transaction date
Purchase
Price
0.46
Quantity 25,000 +inf%
Value US$11,500
3.6
WU MIJIA Non-Executive Director
Transaction date
Sale
Price
1.35
Quantity 20,000 -100.0%
Value US$27,000
3.9
Fu Jian Ping Large shareholder
Transaction date
Sale
Price
1.23
Quantity 1,302,350 -24.6%
Value US$1,601,890
3.6
WU MIJIA
Transaction date
Sale
Price
4.04
Quantity 15,873 -100.0%
Value US$64,127
3.9
Fu Jian Ping Large shareholder
Transaction date
Sale
Price
3.84
Quantity 380,954 -6.7%
Value US$1,462,863
3.6
WU MIJIA
Transaction date
Sale
Price
2.03
Quantity 47,619 -100.0%
Value US$96,667
Najafi Ramin Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.44
Quantity 6,000 +100.0%
Value US$2,640
Najafi Ramin Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.50
Quantity 6,000 +inf%
Value US$3,000
Najafi Ramin Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 166,666 +5.2%
Value US$100,000
Pioneer Pharma (Singapore) Pte. Ltd. Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 2,590,000 +37.0%
Value US$1,554,000
SIECZKAREK MARK M Non-Executive Director
Transaction date
Purchase
Price
0.60
Quantity 166,666 +559.3%
Value US$100,000
Stroman David W. SVP, Ophthalmic Product Devt. Officer
Transaction date
Purchase
Price
0.66
Quantity 10,000 +76.9%
Value US$6,600
PAULSON THOMAS J CFO Officer
Transaction date
Purchase
Price
0.68
Quantity 10,000 +17.2%
Value US$6,800
Najafi Ramin Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.65
Quantity 50,000
Value US$32,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15 S Sale
Kazley Michael John

Chief Executive Officer

Executive Director Large shareholder
58,210 -4.5%
160.78
US$108,437 		58,210 -4.5% 160.78 US$108,437
2026-06-17 2026-06-15 S Sale
1.7
Framework Ventures IV L.P.
Large shareholder
12,958 -37.6%
307.70
US$1,542,304 		12,958 -37.6% 307.70 US$1,542,304
2026-06-17 2026-06-15 S Sale
R01 Fund LP

Chief Executive Officer

Executive Director Large shareholder
97,387 -12.8%
351.95
US$2,435,846 		97,387 -12.8% 351.95 US$2,435,846
2025-04-15 2025-04-08 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
300 +0.0%
0.47
US$140 		300 +0.0% 0.47 US$140
2025-04-15 2025-04-04 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
4,538 +0.4%
0.52
US$2,367 		4,538 +0.4% 0.52 US$2,367
2025-04-15 2025-04-03 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
22,976 +2.3%
0.56
US$12,929 		22,976 +2.3% 0.56 US$12,929
2025-04-15 2025-04-02 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
917 +0.1%
0.58
US$532 		917 +0.1% 0.58 US$532
2025-04-15 2025-04-01 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
19,915 +2.0%
0.59
US$11,650 		19,915 +2.0% 0.59 US$11,650
2025-04-15 2025-03-31 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
21,654 +2.3%
0.59
US$12,776 		21,654 +2.3% 0.59 US$12,776
2025-04-15 2025-03-28 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
49,400 +5.5%
0.61
US$30,253 		49,400 +5.5% 0.61 US$30,253
2025-04-15 2025-03-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
600 +0.1%
0.61
US$365 		600 +0.1% 0.61 US$365
2025-04-15 2025-03-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
18,504 +2.1%
0.62
US$11,380 		18,504 +2.1% 0.62 US$11,380
2025-04-15 2025-03-26 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
13,292 +1.5%
0.61
US$8,095 		13,292 +1.5% 0.61 US$8,095
2025-04-15 2025-03-25 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
22,635 +2.7%
0.61
US$13,807 		22,635 +2.7% 0.61 US$13,807
2025-04-15 2025-03-24 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
100 +0.0%
0.61
US$60 		100 +0.0% 0.61 US$60
2025-04-15 2025-03-21 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
6,372 +0.8%
0.61
US$3,855 		6,372 +0.8% 0.61 US$3,855
2025-04-15 2025-03-20 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
5,320 +0.6%
0.61
US$3,271 		5,320 +0.6% 0.61 US$3,271
2025-04-15 2025-03-19 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
1,500 +0.2%
0.60
US$904 		1,500 +0.2% 0.60 US$904
2025-04-15 2025-03-18 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
14,000 +1.7%
0.63
US$8,820 		14,000 +1.7% 0.63 US$8,820
2025-04-15 2025-03-18 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
10,000 +1.2%
0.63
US$6,300 		10,000 +1.2% 0.63 US$6,300
2025-04-15 2025-03-14 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
25,511 +3.3%
0.63
US$16,072 		25,511 +3.3% 0.63 US$16,072
2025-04-15 2025-03-13 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
34 +0.0%
0.64
US$22 		34 +0.0% 0.64 US$22
2025-04-15 2025-03-12 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
11,837 +1.5%
0.62
US$7,370 		11,837 +1.5% 0.62 US$7,370
2025-04-15 2025-03-11 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
2,148 +0.3%
0.58
US$1,246 		2,148 +0.3% 0.58 US$1,246
2025-04-15 2025-03-10 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
14,645 +1.9%
0.58
US$8,494 		14,645 +1.9% 0.58 US$8,494
2025-04-15 2025-03-07 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
102 +0.0%
0.55
US$56 		102 +0.0% 0.55 US$56
2025-04-15 2025-03-04 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
4,000 +0.5%
0.58
US$2,314 		4,000 +0.5% 0.58 US$2,314
2025-04-15 2025-02-28 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
13,108 +1.8%
0.60
US$7,891 		13,108 +1.8% 0.60 US$7,891
2025-04-15 2025-02-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
385 +0.1%
0.61
US$235 		385 +0.1% 0.61 US$235
2025-04-15 2025-02-26 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
6,302 +0.9%
0.61
US$3,844 		6,302 +0.9% 0.61 US$3,844
2025-04-15 2025-02-25 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
25,033 +3.5%
0.62
US$15,518 		25,033 +3.5% 0.62 US$15,518
2025-04-15 2025-02-24 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
450 +0.1%
0.62
US$279 		450 +0.1% 0.62 US$279
2025-04-15 2025-02-20 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
1,836 +0.3%
0.63
US$1,157 		1,836 +0.3% 0.63 US$1,157
2025-04-15 2025-02-19 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
49,664 +7.6%
0.67
US$33,349 		49,664 +7.6% 0.67 US$33,349
2025-04-15 2025-02-18 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
3,222 +0.5%
0.66
US$2,127 		3,222 +0.5% 0.66 US$2,127
2025-04-15 2025-02-04 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
26,718 +4.3%
0.64
US$16,966 		26,718 +4.3% 0.64 US$16,966
2025-04-15 2025-02-03 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
2,597 +0.4%
0.64
US$1,649 		2,597 +0.4% 0.64 US$1,649
2025-04-15 2025-01-31 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
70,685 +12.9%
0.65
US$45,825 		70,685 +12.9% 0.65 US$45,825
2025-04-15 2025-01-27 B Purchase
2.2
POPLAR POINT CAPITAL PARTNERS LP
Large shareholder
31,703 +6.1%
0.69
US$21,875 		31,703 +6.1% 0.69 US$21,875
2022-12-07 2022-12-06 S Sale
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
1
1.81
US$2 		1 1.81 US$2
2022-12-07 2022-12-06 S Sale
1.8
Kunin Audrey

Chief Product Officer

Officer
1
1.81
US$2 		1 1.81 US$2
2022-11-23 2022-11-21 S Sale
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
5,960 -100.0%
2.10
US$12,545 		5,960 -100.0% 2.10 US$12,545
2022-11-23 2022-11-21 S Sale
1.8
Kunin Audrey

Chief Product Officer

Executive Director
5,960 -100.0%
2.10
US$12,545 		5,960 -100.0% 2.10 US$12,545
2022-09-16 2022-09-14 B Purchase
1.1
Hall Justin

CEO, GC and Director

Executive Director
10,000 +13.7%
0.15
US$1,500 		10,000 +13.7% 0.15 US$1,500
2022-09-16 2022-09-14 S Sale
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
291,368 -58.3%
0.16
US$46,094 		291,368 -58.3% 0.16 US$46,094
2022-09-16 2022-09-14 S Sale
1.8
Kunin Audrey

Chief Product Officer

Executive Director
291,368 -58.3%
0.16
US$46,094 		291,368 -58.3% 0.16 US$46,094
2021-12-06 2021-12-06 B Purchase
1.1
Hall Justin

CEO, GC and Director

Executive Director
69,767 +2049.0%
0.43
US$30,000 		69,767 +2049.0% 0.43 US$30,000
2021-12-06 2021-12-06 B Purchase
0.9
Jones Andrew D.

CFO

Officer
36,765 +40.5%
0.44
US$16,177 		36,765 +40.5% 0.44 US$16,177
2021-12-07 2021-12-03 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
101,650 +25.5%
0.46
US$47,013 		101,650 +25.5% 0.46 US$47,013
2021-12-07 2021-12-03 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
101,650 +25.5%
0.46
US$47,013 		101,650 +25.5% 0.46 US$47,013
2021-12-06 2021-12-03 B Purchase
0.9
Jones Andrew D.

CFO

Officer
8,690 +10.6%
0.44
US$3,824 		8,690 +10.6% 0.44 US$3,824
2021-12-06 2021-12-02 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
262,369 +192.9%
0.48
US$124,888 		262,369 +192.9% 0.48 US$124,888
2021-12-06 2021-12-02 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
262,369 +192.9%
0.48
US$124,888 		262,369 +192.9% 0.48 US$124,888
2021-12-03 2021-12-01 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
14,848 +12.3%
0.49
US$7,276 		14,848 +12.3% 0.49 US$7,276
2021-12-03 2021-12-01 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
14,848 +12.3%
0.49
US$7,276 		14,848 +12.3% 0.49 US$7,276
2021-12-02 2021-11-30 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
30,000 +32.9%
0.46
US$13,800 		30,000 +32.9% 0.46 US$13,800
2021-12-02 2021-11-30 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
30,000 +32.9%
0.46
US$13,800 		30,000 +32.9% 0.46 US$13,800
2021-11-24 2021-11-23 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
66,133 +264.5%
0.46
US$30,368 		66,133 +264.5% 0.46 US$30,368
2021-11-24 2021-11-23 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
66,133 +264.5%
0.46
US$30,368 		66,133 +264.5% 0.46 US$30,368
2021-11-24 2021-11-22 B Purchase
1.8
Kunin Jeffrey

President, DERMAdoctor, LLC

Officer
25,000 +inf%
0.46
US$11,500 		25,000 +inf% 0.46 US$11,500
2021-11-24 2021-11-22 B Purchase
1.8
Kunin Audrey

Chief Product Officer

Officer
25,000 +inf%
0.46
US$11,500 		25,000 +inf% 0.46 US$11,500
2020-08-19 2020-08-17 S Sale
3.6
WU MIJIA
Non-Executive Director
20,000 -100.0%
1.35
US$27,000 		20,000 -100.0% 1.35 US$27,000
2020-08-04 2020-08-01 S Sale
3.9
Fu Jian Ping
Large shareholder
1,302,350 -24.6%
1.23
US$1,601,890 		1,302,350 -24.6% 1.23 US$1,601,890
2019-06-13 2019-06-11 S Sale
3.6
WU MIJIA
15,873 -100.0%
4.04
US$64,127 		15,873 -100.0% 4.04 US$64,127
2019-06-13 2019-06-11 S Sale
3.9
Fu Jian Ping
Large shareholder
380,954 -6.7%
3.84
US$1,462,863 		380,954 -6.7% 3.84 US$1,462,863
2019-06-13 2019-06-11 S Sale
3.4
Pioneer Pharma (Hong Kong) Co Ltd
Large shareholder
24,326 -0.5%
4.04
US$98,277 		24,326 -0.5% 4.04 US$98,277
2019-06-13 2019-06-10 S Sale
3.6
WU MIJIA
47,619 -100.0%
2.03
US$96,667 		47,619 -100.0% 2.03 US$96,667
2015-08-21 2015-08-20 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
6,000 +100.0%
0.44
US$2,640 		6,000 +100.0% 0.44 US$2,640
2015-08-21 2015-08-19 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
6,000 +inf%
0.50
US$3,000 		6,000 +inf% 0.50 US$3,000
2015-03-05 2015-03-03 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
166,666 +5.2%
0.60
US$100,000 		166,666 +5.2% 0.60 US$100,000
2015-03-05 2015-03-03 B Purchase Pioneer Pharma (Singapore) Pte. Ltd. Large shareholder
2,590,000 +37.0%
0.60
US$1,554,000 		2,590,000 +37.0% 0.60 US$1,554,000
2015-03-05 2015-03-03 B Purchase SIECZKAREK MARK M Non-Executive Director
166,666 +559.3%
0.60
US$100,000 		166,666 +559.3% 0.60 US$100,000
2014-12-16 2014-12-12 B Purchase Stroman David W.

SVP, Ophthalmic Product Devt.

Officer
10,000 +76.9%
0.66
US$6,600 		10,000 +76.9% 0.66 US$6,600
2014-12-15 2014-12-12 B Purchase PAULSON THOMAS J

CFO

Officer
10,000 +17.2%
0.68
US$6,800 		10,000 +17.2% 0.68 US$6,800
2014-12-15 2014-12-12 B Purchase Najafi Ramin

Chief Executive Officer

Executive Director Large shareholder
50,000
0.65
US$32,500 		50,000 0.65 US$32,500
Explore more

More insider trading research around Stablecoin Development Corp

More insider trades in United States
Similar Technology companies with insider activity
More Financial Technology (Fintech) & Infrastructure companies with insider activity
More Financial Technology (Fintech) & Infrastructure companies with insider activity
Insider trading in North America